Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
Srinivasa Reddy Bonam, Christine Tranchant, Sylviane Muller
Cells (2021) Vol. 10, Iss. 12, pp. 3547-3547
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
Marija Vidović, Milena Rikalović
Cells (2022) Vol. 11, Iss. 11, pp. 1732-1732
Open Access | Times Cited: 90
The role of lysosomes in metabolic and autoimmune diseases
Frédéric Gros, Sylviane Muller
Nature Reviews Nephrology (2023) Vol. 19, Iss. 6, pp. 366-383
Closed Access | Times Cited: 70
Autophagy in Parkinson’s Disease
Lior Nechushtai, Dan Frenkel, Ronit Pinkas‐Kramarski
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1435-1435
Open Access | Times Cited: 31
DNA methylation profiling at base-pair resolution reveals unique epigenetic features of early-onset colorectal cancer in underrepresented populations
Jason Sheng Li, Karen Riggins, Li Yang, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic potential
Jashanpreet Kaur, Veerta Sharma, Heena Khan, et al.
Brain Research (2025), pp. 149568-149568
Closed Access | Times Cited: 1
The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity
Jiaxue Chen, Jingke Xu, Ping Huang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112866-112866
Open Access | Times Cited: 29
Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System
Kenneth Maiese
Biomolecules (2023) Vol. 13, Iss. 5, pp. 816-816
Open Access | Times Cited: 21
Olfactory dysfunction and its related molecular mechanisms in Parkinson’s disease
Yingying Gu, Jiaying Zhang, Xinru Zhao, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 3, pp. 583-590
Open Access | Times Cited: 18
Antioxidants activities of phytochemicals perspective modulation of autophagy and apoptosis to treating cancer
Kazi Rejvee Ahmed, Md. Masudur Rahman, Md. Nahidul Islam, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116497-116497
Open Access | Times Cited: 7
The Metabolic Basis for Nervous System Dysfunction in Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease
Kenneth Maiese
Current Neurovascular Research (2023) Vol. 20, Iss. 3, pp. 314-333
Open Access | Times Cited: 15
Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s disease
Dani Flinkman, Ye Hong, Jelena Gnjatovic, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Alpha synuclein and inflammaging
Geneviève L Putnam, Robert W. Maitta
Heliyon (2025) Vol. 11, Iss. 2, pp. e41981-e41981
Open Access
Chaperone-Mediated Autophagy and Its Implications for Neurodegeneration and Cancer
Masresha Ahmed Assaye, Solomon Tebeje Gizaw
International Journal of General Medicine (2022) Vol. Volume 15, pp. 5635-5649
Open Access | Times Cited: 19
Thioredoxin-1 decreases alpha-synuclein induced by MPTP through promoting autophagy-lysosome pathway
Rou Gu, Liping Bai, Fang Yan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
The role of microglial autophagy in Parkinson’s disease
Rui Zhu, Yuyi Luo, Shangang Li, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 18
Exploring Retrograde Trafficking: Mechanisms and Consequences in Cancer and Disease
Rachel Bingham, Helen O. McCarthy, Niamh E. Buckley
Traffic (2024) Vol. 25, Iss. 2
Open Access | Times Cited: 3
Resveratrol Promotes Autophagy to Improve neuronal Injury in Parkinson’s Disease by Regulating SNHG1/miR-128-3p/SNCA Axis
Dongfang Shen, Huiping Qi, Weina Zhang, et al.
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1124-1124
Open Access | Times Cited: 7
The impact of VPS35 D620N mutation on alternative autophagy and its reversal by estrogen in Parkinson's disease
Tomotaka Shiraishi, Keiko Bono, Hiromi Hiraki, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Inhibition of monoamine oxidases by heterocyclic derived conjugated dienones: synthesis, in vitro, and in silico investigations
Sunil Kumar, Bishnu Prasad Pandey, Mohamed A. Abdelgawad, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
TMEM106B knockdown exhibits a neuroprotective effect in Parkinson's disease models via regulating autophagy-lysosome pathway
Yumei Liu, Kunpeng Qin, Kaixin Dou, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 1, pp. 167553-167553
Open Access | Times Cited: 2
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 2
A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology
Jessica Chedid, Adahir Labrador‐Garrido, Siying Zhong, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 8, pp. 102260-102260
Open Access | Times Cited: 11
Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease
Kaifu Ke, Xiao-Su Gu, Hai‐Ying Zhang, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 5, pp. 1099-1099
Open Access | Times Cited: 11
The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
Luiza J. Chwiszczuk, Monica H. Breitve, Bjørn-Eivind Bordewick Kirsebom, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 6
Celastrol Downmodulates Alpha-Synuclein-Specific T Cell Responses by Mediating Antigen Trafficking in Dendritic Cells
Lam Ng, Xiaohui Wang, Chuanbin Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top